Tetracycline-regulated gene expression in the brain

The possibility of regulating individual gene activities in the mouse brain via the tetracycline-controlled transcriptional activation systems has sparked the development of novel mouse models aimed at elucidating the molecular mechanisms of brain disorders such as Huntington's, prion and Parkinson's diseases. In the past year, novel experimental strategies and methodological advances have emerged, contributing to the resolution of some of the initial limitations of these regulatory systems.

[1]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y. Saitoh,et al.  Long-Term Functional Assessment of Encapsulated Cells Transfected with Tet-On System , 1999, Cell transplantation.

[3]  J. Mallet,et al.  Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[5]  R. Haberman,et al.  Inducible long-term gene expression in brain with adeno-associated virus gene transfer , 1998, Gene Therapy.

[6]  E. Kandel,et al.  Genetic and Pharmacological Evidence for a Novel, Intermediate Phase of Long-Term Potentiation Suppressed by Calcineurin , 1998, Cell.

[7]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[8]  E. Kandel,et al.  The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Hermann Bujard,et al.  A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells , 1999, The journal of gene medicine.

[10]  J. Mallet,et al.  A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors , 1999, Nature Biotechnology.

[11]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Spinella,et al.  Expression of Green Fluorescent Protein in Oligodendrocytes in a Time- and Level-Controllable Fashion with a Tetracycline-Regulated System , 1999, Molecular medicine.

[13]  M. Gossen,et al.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Prusiner,et al.  Doxycycline control of prion protein transgene expression modulates prion disease in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[16]  M. Gossen,et al.  Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.

[17]  J. Mallet,et al.  Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes. , 1999, Human gene therapy.

[18]  Eric R Kandel,et al.  Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.

[19]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[20]  E. Kandel,et al.  Inducible and Reversible Gene Expression with the rtTA System for the Study of Memory , 1998, Neuron.

[21]  Wen-Hwa Lee,et al.  Temporal, spatial, and cell type–specific control of Cre-mediated DNA recombination in transgenic mice , 1999, Nature Biotechnology.

[22]  M. Gossen,et al.  Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[24]  J. Uney,et al.  Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system , 1998, Nature Biotechnology.

[25]  Studies on Conditional Gene Expression in the Brain , 1999, Annals of the New York Academy of Sciences.

[26]  M. Gossen,et al.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.